thiophenes has been researched along with tacrolimus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chamoto, K; Fukuda, Y; Goto, M; Hayashi, Y; Inoue, H; Kadoshima-Yamaoka, K; Miura, K; Murafuji, H; Murakawa, M; Nagahira, K; Nakatsuka, T; Nishimura, T; Tanaka, Y | 1 |
| Barbara, A; Fromigué, O; Haÿ, E; Marie, PJ | 1 |
| Goldust, M; Raghifar, R; Rezaee, E | 1 |
| Goldust, M; Hemayat, S; Raghifar, R; Rezaee, E | 1 |
| Gotthardt, DN; Schemmer, P; Stremmel, W; Wannhoff, A; Weiss, KH | 1 |
| Azizzadeh, M; Bagheri, B; Pahlevan, D | 1 |
| Bobay, BG; Ciofani, M; Cole, DC; DeBouver, ND; Fox, D; Heitman, J; Hong, J; Hoy, MJ; Juvvadi, PR; Lee, H; Lim, WY; Park, E; Pierce, PG; Steinbach, W | 1 |
3 trial(s) available for thiophenes and tacrolimus
| Article | Year |
|---|---|
Treatment of seborrheic dermatitis: comparison of sertaconazole 2 % cream versus pimecrolimus 1 % cream.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Child; Dermatitis, Seborrheic; Dermatologic Agents; Female; Humans; Imidazoles; Iran; Male; Middle Aged; Patient Satisfaction; Severity of Illness Index; Skin; Skin Cream; Tacrolimus; Thiophenes; Treatment Outcome; Young Adult | 2013 |
Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs. tacrolimus 0.03% cream.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Dermatitis, Seborrheic; Female; Humans; Imidazoles; Immunosuppressive Agents; Male; Middle Aged; Tacrolimus; Thiophenes; Young Adult | 2013 |
The efficacy and safety of pimecrolimus 1% cream vs. sertaconazole 2% cream in the treatment of patients with facial seborrhoeic dermatitis: a randomized blinded trial.
Topics: Dermatitis, Seborrheic; Dermatologic Agents; Double-Blind Method; Emollients; Humans; Imidazoles; Tacrolimus; Thiophenes; Treatment Outcome | 2022 |
4 other study(ies) available for thiophenes and tacrolimus
| Article | Year |
|---|---|
Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte.
Topics: Animals; Bucladesine; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Cell Line; Colforsin; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Female; Flow Cytometry; Immunosuppressive Agents; Indicators and Reagents; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Pyrazoles; Rolipram; Spleen; T-Lymphocytes, Cytotoxic; Tacrolimus; Thiophenes | 2009 |
Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate.
Topics: Animals; beta Catenin; Blotting, Western; Calcineurin Inhibitors; Cell Differentiation; Cell Line; Cell Nucleus; Cells, Cultured; Cyclosporine; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; NFATC Transcription Factors; Organometallic Compounds; Osteoblasts; Protein Transport; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tacrolimus; Thiophenes; Transcription, Genetic; Wnt Proteins; Wnt-5a Protein; Wnt3 Protein; Wnt3A Protein | 2010 |
Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A.
Topics: Aged; Anticoagulants; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Hemorrhage; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Morpholines; Retrospective Studies; Risk Factors; Rivaroxaban; Tacrolimus; Thiophenes | 2014 |
Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit
Topics: Animals; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Cryptococcus neoformans; Imidazoles; Immunosuppressive Agents; Mammals; Mice; Sulfonamides; Tacrolimus; Tacrolimus Binding Protein 1A; Thiophenes; Virulence Factors | 2022 |